Showing Form 4 filings for INBX
Pre-configured institutional-grade criteria for instant high-conviction screening
Multiple insiders buying stock within the last 30 days
Direct open-market purchases by Chief Executive Officers
Financial chiefs and top corporate officers accumulating shares
Institutional-scale insider purchases of $1,000,000 or greater
Insiders increasing their overall equity ownership by over 20%
High-value executive divestments by CEOs and CFOs over $1M
Inhibrx Biosciences, Inc.
Price
$100.54
Shares
47,540
Ownership
1,197,517
Value/Share
Multiple Insiders
2 Insiders
Biological Products, (No Diagnostic Substances)
Industry
$104.82
37,500
1,187,477
$99.88
10,000
960,413
Lappe Mark
CEO